Literature DB >> 7877910

Retinopathy of prematurity.

D L Phelps1.   

Abstract

Retinopathy of prematurity is a common disorder among extremely low-birthweight preterm infants and may cause total vision loss in as many as 2% to 4% of those weighing less than 2 pounds at birth. Regular examinations begun in the neonatal intensive care unit permit early detection and treatment of progressive ROP and allow a reduction in visual impairment. Infants whose ROP has regressed should continue to receive regular ophthalmologic follow-up for the detection and treatment of myopia and strabismus and, if they have cicatricial sequelae, late retinal detachments as teens or adults. Early intervention and special education programs are important for the children whose vision loss is significant.

Entities:  

Mesh:

Year:  1995        PMID: 7877910     DOI: 10.1542/pir.16-2-50

Source DB:  PubMed          Journal:  Pediatr Rev        ISSN: 0191-9601


  11 in total

1.  Pharmacologic and genetic manipulation of MMP-2 and -9 affects retinal neovascularization in rodent models of OIR.

Authors:  Joshua M Barnett; Gary W McCollum; Jessica A Fowler; James J-W Duan; Jesse D Kay; Rui-Qin Liu; David P Bingaman; John S Penn
Journal:  Invest Ophthalmol Vis Sci       Date:  2007-02       Impact factor: 4.799

2.  Effect of trace elements on retinopathy of prematurity.

Authors:  Hong Yang; Yi Ding; Ling Chen
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2007-10

3.  TWEAK/Fn14 pathway is a novel mediator of retinal neovascularization.

Authors:  Hossein Ameri; Hua Liu; Rong Liu; Yonju Ha; Adriana A Paulucci-Holthauzen; Shuqun Hu; Massoud Motamedi; Bernard F Godley; Ronald G Tilton; Wenbo Zhang
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-02-10       Impact factor: 4.799

4.  Vision impairment in Liverpool: prevalence and morbidity.

Authors:  M Rogers
Journal:  Arch Dis Child       Date:  1996-04       Impact factor: 3.791

5.  Retinal angiogenesis is mediated by an interaction between the angiotensin type 2 receptor, VEGF, and angiopoietin.

Authors:  Stella Sarlos; Bishoy Rizkalla; Christina J Moravski; Zemin Cao; Mark E Cooper; Jennifer L Wilkinson-Berka
Journal:  Am J Pathol       Date:  2003-09       Impact factor: 4.307

6.  Risk factors and laser therapy for retinopathy of prematurity in neonatal intensive care unit.

Authors:  Li Liu; Tian Tian; Chong-Xun Zheng; Vatavu Ileana; Anca Ioana; Ciomartan Tatiana; Racovitan Oana
Journal:  World J Pediatr       Date:  2009-11-13       Impact factor: 2.764

7.  Adopting Western Retinopathy of Prematurity Screening Programs in Eastern Countries, are we Screening Properly?

Authors:  Almutez Gharaibeh; Mohammed Khassawneh; Wadah Khriesat; Shadi Alkhatib; Yazan Migdadi
Journal:  Middle East Afr J Ophthalmol       Date:  2011-07

8.  c-abl is required for the development of hyperoxia-induced retinopathy.

Authors:  I Nunes; R D Higgins; L Zanetta; P Shamamian; S P Goff
Journal:  J Exp Med       Date:  2001-06-18       Impact factor: 14.307

9.  Hydrogen Sulfide Contributes to Retinal Neovascularization in Ischemia-Induced Retinopathy.

Authors:  David Gersztenkorn; Ciro Coletta; Shuang Zhu; Yonju Ha; Hua Liu; Hongyan Tie; Jia Zhou; Csaba Szabo; Wenbo Zhang; Massoud Motamedi
Journal:  Invest Ophthalmol Vis Sci       Date:  2016-06-01       Impact factor: 4.799

10.  CCN1/Cyr61-PI3K/AKT signaling promotes retinal neovascularization in oxygen-induced retinopathy.

Authors:  Yu Di; Yiou Zhang; Qingzhu Nie; Xiaolong Chen
Journal:  Int J Mol Med       Date:  2015-10-12       Impact factor: 4.101

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.